ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 3 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,377,517 | -25.7% | 51,266 | -1.4% | 1.78% | -20.4% |
| Q2 2023 | $1,854,677 | +40.8% | 52,010 | +0.3% | 2.23% | +22.3% |
| Q1 2023 | $1,317,701 | -64.7% | 51,878 | -43.7% | 1.83% | -49.1% |
| Q4 2022 | $3,735,373 | +46.7% | 92,095 | +19.5% | 3.59% | +46.4% |
| Q3 2022 | $2,546,000 | +10.8% | 77,049 | +18.1% | 2.45% | -2.1% |
| Q2 2022 | $2,297,000 | -43.7% | 65,239 | -26.5% | 2.50% | -11.8% |
| Q1 2022 | $4,082,000 | -46.7% | 88,749 | -23.2% | 2.84% | -22.9% |
| Q4 2021 | $7,663,000 | +16.4% | 115,580 | +9.6% | 3.68% | +25.9% |
| Q3 2021 | $6,586,000 | +2.2% | 105,491 | +35.6% | 2.92% | -1.6% |
| Q2 2021 | $6,445,000 | +33.2% | 77,815 | +6.7% | 2.97% | +3.9% |
| Q1 2021 | $4,837,000 | +30.6% | 72,948 | +51.1% | 2.86% | +1.3% |
| Q4 2020 | $3,703,000 | – | 48,265 | – | 2.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |